No Data
Jiangnan Mould & Plastic Technology reduced its shareholding in Bank Of Jiangsu by 25 million shares, and multiple listed banks have seen shareholding reductions by shareholders this year.
① On the evening of December 11, the listed company Jiangnan Mould & Plastic Technology (000700) announced that it had recently reduced its shareholding in Bank Of Jiangsu by 25 million shares, with a transaction amount of 0.226 billion yuan. ② Throughout the year, there have been multiple cases where shares of listed banks have been reduced by Shareholders, involving Bank Of Changsha, Bank Of Hangzhou, Qilu Bank, and others.
Are Robust Financials Driving The Recent Rally In Jiangnan Mould & Plastic Technology Co., Ltd.'s (SZSE:000700) Stock?
Jiangnan mould & plastic technology (000700.SZ): The proportion of direct exports from domestic to foreign markets is relatively small.
According to a statement made on December 9 by Gelonghui, jiangnan mould & plastic technology (000700.SZ) mentioned on the investor interaction platform that the company's overseas income mainly comes from the business of its subsidiary in Mexico, with a relatively small proportion of direct exports from the domestic market to overseas.
Jiangnan mould & plastic technology (000700.SZ): Mexicana Minghua currently has sufficient production capacity.
On December 9, Glonghui reported that jiangnan mould & plastic technology (000700.SZ) stated on the investor interaction platform that Mexico Minghua currently has sufficient production capacity.
Jiangnan mould & plastic technology (000700.SZ): There are no plans to divest Mingci hospital.
Gelonghui November 18th | jiangnan mould & plastic technology (000700.SZ) stated in investor relations that the company has no plans to divest Mingci Hospital. As of the end of October, the hospital has seen a significant increase in outpatient visits, discharges, and surgeries compared to the same period last year. However, due to the intensive and substantial adjustments in national and local-level medical insurance settlement policies this year, including in Wuxi, the hospital has experienced a significant loss in current-stage revenue. Going forward, the hospital will proactively adapt to the changes in the new medical insurance settlement policies through business restructuring and cost optimization. After years of operation, Mingci Hospital has established a strong presence in Wuxi and surrounding areas.
jiangnan mould & plastic technology (000700.SZ): The equity-held company Beiqi Mould & Plastic has established production bases in Peking, Hefei, Chongqing, Chengdu, and Zhuzhou.
Jiangnan Mould & Plastic Technology (000700.SZ) stated in investor relations that the company currently has production bases in Wuxi Jiangyin, Shanghai, Shenyang, Wuhan, Yantai, and Mexico, with R&D centers in Beijing, Shanghai, and Jiangyin. The company's affiliated company, Beiqi Mould, has established production bases in Beijing, Hefei, Chongqing, Chengdu, Zhuzhou and other places. The company's production base layout is already quite comprehensive, in recent years the company mainly improves capacity by transforming production line technology and continuously enhancing production efficiency.
Jiangnan Mould & Plastic Technology Co., Ltd. (SZSE:000700) Surges 38% Yet Its Low P/E Is No Reason For Excitement
No Data
